News

Survey results presented at ACAAI’s annual Scientific Meeting demonstrate the limited influence of elimination diets for reducing symptoms of AD.

The application of a clinically validated moisturizer before mask-wearing was shown to significantly improve skin barrier function and reduce irritation.

Click here to answer today’s poll and read more about the perception of telehealth treatment in dermatology.

We want to know: Will you be attending the conference in Las Vegas later this week?

In a Dermatology Times Case-Based Roundtable event, Ted Lain, MD, MBA, FAAD, reviewed 2 cases of patients with vitiligo treated with ruxolitinib.

Christopher Bunick, MD, PhD, addresses common barriers in recognizing and treating chronic hand eczema and its significant impact on quality of life.

Understanding the varying tax aspects of S corporations and C corporations is an important first step in determining which structure will work best for your practice.

In a recent Dermatology Times DermView video series, “Advancing Care in Pediatric Plaque Psoriasis: Emerging Treatments and Management Strategies," Karan Lal, DO, and Helen Shin, MD, discuss pediatric psoriasis and its prevalence.

Researchers behind a recent study found that patients with liver disease had a significantly higher prevalence of chronic pruritus.

In a Dermatology Times Case-Based Roundtable event, Heather Woolery-Lloyd, MD, shared pearls for challenging acne cases.

Lal emphasizes the dual approach of combining medical and cosmetic dermatology to effectively address skin issues like hyperpigmentation.

Given the complexity of the underlying inflammation in patients with AD, an increased understanding of the OX40L pathway can improve our understanding of AD pathogenesis.

Shi addresses one of the NEA's Eczema Awareness Month weekly themes, "Creative ways to manage your eczema."

Whether you're a novice or a seasoned expert, there's always more to learn and refine, ensuring that dermatology continues to advance with precision and care.

A recent study revealed that patients with HS have a 23% prevalence of IA, emphasizing the need for routine screening in dermatologic practice.

Christophe Bourdon, CEO, discusses LEO Pharma's groundbreaking presentations at EADV, delgocitinib's US pending approval, and the company's commitment to addressing chronic hand eczema.

Lio addresses one of the NEA's Eczema Awareness Month weekly themes, "What is eczema?"

Song stressed the need for careful therapy selection in patients with comorbid conditions to avoid exacerbating health issues.

In case you missed it, this week we had news about delgocitinib's launch in Germany, the FDA clearance of Accure's laser system for long-term acne treatment, BE BOLD study highlights, and more.

The multicenter trial reported high response rates and low risk of discontinuation for treating long-term chronic inducible urticaria.

Historically, research and clinical practice often have overlooked the distinct manifestations and treatment needs of patients with skin of color who have psoriasis.

This represents the second approval of Zoryve outside the US.

The case series found dupilumab led to improvements in skin condition and a reduction in bacterial infections for pediatric patients with Hyper-IgE syndrome.

Forlenza addresses one of the NEA's Eczema Awareness Month weekly themes, "Tools for living your most ecz-pressive life with eczema."

In a Dermatology Times Case-Based Roundtable event, James Del Rosso, DO, shared pearls for challenging acne cases.

With this combined administration, patients saw noticeable and lasting improvements in severe cases of AD.

Studies show conflicting serum levels of zinc and copper in vitiligo patients, indicating a need for further research.

The study represents the first to evaluate health care resource utilization among individuals with PN in England.

Developed by a panel of global dermatology experts, the SQS addresses the multifaceted nature of skin quality.